Type 2 Diabetes Clinical Trials in Seoul
11 recruitingSeoul, South Korea
Showing 1–11 of 11 trials
Recruiting
Phase 1
Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration of L03TD1 in Healthy Volunteers
Type 2 Diabetes Mellitus (T2DM)
Celltrion48 enrolled1 locationNCT07533539
Recruiting
Phase 4
Glycemic Variability of Combination Therapies in T2DM
Type 2 Diabetes Mellitus (T2DM)
JW Pharmaceutical178 enrolled1 locationNCT07442006
Recruiting
Phase 3
Evaluate the Efficacy and Safety of CMG190303 in Patients With Type 2 Diabetes and Dyslipidemia
Type 2 DiabetesDyslipidemia
CMG Pharmaceutical Co. Ltd240 enrolled24 locationsNCT06772168
Recruiting
Phase 3
A Randomized, Double-blind, Multi-center, Active-controlled, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of THP-00101, THP-00102, and THP-00103 in Subjects With T2DM and Essential Hypertension
HypertensionType 2 Diabetes
THPharm Corp.221 enrolled2 locationsNCT06647745
Recruiting
Phase 4
Effects of Enavogliflozin on Coronary Microvascular and Cardiac Function in Obesity
Obesity and Type 2 Diabetes
Korea University Anam Hospital30 enrolled1 locationNCT06782139
Recruiting
Not Applicable
A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH)
Type 2 Diabetes
Kyu Chang Won5,950 enrolled2 locationsNCT06627322
Recruiting
Phase 2
To Assess the Efficacy and Safety of HD-6277 in Adult Patients With Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise
Type 2 Diabetes Mellitus (T2DM)
Hyundai Pharm160 enrolled1 locationNCT06647550
Recruiting
A Study to Identify the Risk of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients With Type 2 Diabetes in Clinical Practice and to Evaluate the Clinical Usefulness of Dapagliflozin/Pioglitazone Combination Therapy
Type 2 Diabetes
Boryung Pharmaceutical Co., Ltd10,000 enrolled2 locationsNCT06649162
Recruiting
Not Applicable
To Assess With Ezefeno Tab. in Patients With Dyslipidemia and T2DM
DyslipidemiasT2DM (Type 2 Diabetes Mellitus)
Korea University Anam Hospital3,958 enrolled1 locationNCT06293417
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of BR1019A and BR1019B Combination Therapy
Essential HypertensionType 2 Diabetes Mellitus
Boryung Pharmaceutical Co., Ltd276 enrolled2 locationsNCT06220773
Recruiting
Phase 3
A Study to Investigate the Effect of DWP16001 as add-on Therapy to Drug A in Patients With Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus
Daewoong Pharmaceutical Co. LTD.240 enrolled1 locationNCT05466643